Literature DB >> 12235331

Benign versus malignant hepatic nodules: MR imaging findings with pathologic correlation.

Shahid M Hussain1, Pieter E Zondervan, Jan N M IJzermans, Solko W Schalm, Rob A de Man, Gabriel P Krestin.   

Abstract

According to the currently used nomenclature, there are only two types of hepatocellular nodular lesions: regenerative lesions and dysplastic or neoplastic lesions. Regenerative nodules include monoacinar regenerative nodules, multiacinar regenerative nodules, cirrhotic nodules, segmental or lobar hyperplasia, and focal nodular hyperplasia. Dysplastic or neoplastic nodules include hepatocellular adenoma, dysplastic foci, dysplastic nodules, and hepatocellular carcinoma (HCC). Many of these types of hepatic nodules play a role in the de novo and stepwise carcinogenesis of HCC, which comprises the following steps: regenerative nodule, low-grade dysplastic nodule, high-grade dysplastic nodule, small HCC, and large HCC. State-of-the-art magnetic resonance (MR) imaging facilitates detection and characterization in most cases of hepatic nodules. State-of-the-art MR imaging includes single-shot fast spin-echo imaging, in-phase and opposed-phase T1-weighted gradient-echo imaging, T2-weighted fast spin-echo imaging with fat saturation, and two-dimensional or three-dimensional dynamic multiphase contrast material-enhanced imaging.

Entities:  

Mesh:

Year:  2002        PMID: 12235331     DOI: 10.1148/radiographics.22.5.g02se061023

Source DB:  PubMed          Journal:  Radiographics        ISSN: 0271-5333            Impact factor:   5.333


  41 in total

1.  Detection of focal liver lesions in cirrhotic liver using contrast-enhanced ultrasound.

Authors:  Grace Lai-Hung Wong; Hui-Xiong Xu; Xiao-Yan Xie
Journal:  World J Radiol       Date:  2009-12-31

2.  Gene expression profile related to the progression of preneoplastic nodules toward hepatocellular carcinoma in rats.

Authors:  Julio Isael Pérez-Carreón; Cristina López-García; Samia Fattel-Fazenda; Evelia Arce-Popoca; Leticia Alemán-Lazarini; Sergio Hernández-García; Véronique Le Berre; Sergueï Sokol; Jean Marie Francois; Saúl Villa-Treviño
Journal:  Neoplasia       Date:  2006-05       Impact factor: 5.715

3.  Diffusion-weighted MRI provides additional value to conventional dynamic contrast-enhanced MRI for detection of hepatocellular carcinoma.

Authors:  Vincent Vandecaveye; Frederik De Keyzer; Chris Verslype; Katya Op de Beeck; Mina Komuta; Baki Topal; Ilse Roebben; Didier Bielen; Tania Roskams; Frederik Nevens; Steven Dymarkowski
Journal:  Eur Radiol       Date:  2009-05-14       Impact factor: 5.315

Review 4.  Magnetic resonance imaging of the cirrhotic liver: An update.

Authors:  Agnes Watanabe; Miguel Ramalho; Mamdoh AlObaidy; Hye Jin Kim; Fernanda G Velloni; Richard C Semelka
Journal:  World J Hepatol       Date:  2015-03-27

5.  Contrast-enhanced ultrasound of hepatocellular carcinoma: correlation between enhancement pattern and cellular differentiation on histopathlogy.

Authors:  F Loria; G Loria; S Basile; G Crea; D Randazzo; L Frosina
Journal:  Updates Surg       Date:  2012-10-07

Review 6.  Imaging of liver cancer.

Authors:  Ben Ariff; Claire R Lloyd; Sameer Khan; Mohamed Shariff; Andrew V Thillainayagam; Devinder S Bansi; Shahid A Khan; Simon D Taylor-Robinson; Adrian K P Lim
Journal:  World J Gastroenterol       Date:  2009-03-21       Impact factor: 5.742

Review 7.  Clinical value of MRI liver-specific contrast agents: a tailored examination for a confident non-invasive diagnosis of focal liver lesions.

Authors:  Ahmed Ba-Ssalamah; Martin Uffmann; Sanjai Saini; Nina Bastati; Christian Herold; Wolfgang Schima
Journal:  Eur Radiol       Date:  2008-09-23       Impact factor: 5.315

8.  Efficacy of early treatment on 52 patients with preneoplastic hepatitis B virus-associated hepatocellular carcinoma by compound Phyllanthus Urinaria L.

Authors:  Guang-dong Tong; Xi Zhang; Da-qiao Zhou; Chun-shan Wei; Jin-song He; Chun-ling Xiao; Xin-liang Liu; Ying-jun Zheng; Si-nuan Chen; Hai-hong Tang
Journal:  Chin J Integr Med       Date:  2013-03-25       Impact factor: 1.978

9.  Detection of mutant p53 in hepatocellular cancer from Turkey and its correlation with clinicopathologic parameters.

Authors:  Cem Cengiz; Ulus S Akarca; Erdem Goker; Gul Yuce
Journal:  Dig Dis Sci       Date:  2003-05       Impact factor: 3.199

10.  SPIO-enhanced MRI findings of well-differentiated hepatocellular carcinomas: correlation with MDCT findings.

Authors:  Seong Hyun Kim; Won Jae Lee; Hyo K Lim; Cheol Keun Park
Journal:  Korean J Radiol       Date:  2009-03-03       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.